1962
DOI: 10.1210/jcem-22-3-281
|View full text |Cite
|
Sign up to set email alerts
|

Response to an llβ-Hydroxylase Inhibitor (SU-4885) in Males with Adrenal Hyperplasia and in Their Parents

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
9
0

Year Published

1962
1962
1987
1987

Publication Types

Select...
7
3

Relationship

0
10

Authors

Journals

citations
Cited by 33 publications
(9 citation statements)
references
References 0 publications
0
9
0
Order By: Relevance
“…Administration of this compound to normal man results in the accumulation of 17,21-dihydroxy-A4-pregnene-3,20-dione and other ll-deoxysteroids in the urine. Migeon and colleagues (209) administered SU 4885 to patients with the adrenogenital syndrome and defective C-21 hydroxylation. As antici pated, C-11 and C-21 dideoxysteroid metabolites accumulated in the urine.…”
Section: Genetic Defects In Steroid Metabolismmentioning
confidence: 99%
“…Administration of this compound to normal man results in the accumulation of 17,21-dihydroxy-A4-pregnene-3,20-dione and other ll-deoxysteroids in the urine. Migeon and colleagues (209) administered SU 4885 to patients with the adrenogenital syndrome and defective C-21 hydroxylation. As antici pated, C-11 and C-21 dideoxysteroid metabolites accumulated in the urine.…”
Section: Genetic Defects In Steroid Metabolismmentioning
confidence: 99%
“…Since no clinical abnormality is presented by heterozygous subjects, numerous biological in¬ vestigations have been undertaken in order to detect any minor impairments of 21-hydroxylation which they may have. One manifestation is the presence of excessive urinary pregnanetriol following ACTH (Childs et al 1956) or metyrapone tests (Cleveland et al 1962). However, the results of such tests have shown considerable overlap between heterozygous and control sub¬ jects.…”
mentioning
confidence: 99%
“…There is no true difference in the sex ratio (Childs et al, 1956;Prader et al, 1962;Prader and Anders, 1962). Up to the present it has not been possible to detect the heterozygous carrier of the gene (Childs et al, 1956;Cleveland and Migeon, 1960). Prader (1958) has estimated an incidence of the gene of 1: 37 5 in the general population in Switzerland, which leads to one adrenogenital syndrome patient among every 5,000 births in Switzerland.…”
Section: Iv-adrenocortical Hypofunctionmentioning
confidence: 99%